|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM211500941 |
003 |
DE-627 |
005 |
20231224013650.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2011 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2011.08.005
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0705.xml
|
035 |
|
|
|a (DE-627)NLM211500941
|
035 |
|
|
|a (NLM)21920821
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Dolff, Sebastian
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 20.12.2011
|
500 |
|
|
|a Date Revised 18.03.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2011 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Systemic lupus erythematosus (SLE) is an autoimmune disease accompanied by disturbed T-cell homeostasis. Dysbalance of T-helper-cell (Th) subsets (Th1/Th2/Th17) and regulatory T-cells (T(regs)) is suggested to contribute to the pathogenesis of SLE. Recent reports suggest functional deviation of T(regs) in terms of producing IL-17A, a process that may be aberrant in SLE. Therefore, we analyzed these T-cell subsets in SLE to test the hypothesis that aberrant T-cell subset skewing is present in SLE-patients. We investigated simultaneously the intracellular cytokines IFN-γ, IL-4 and IL-17A in CD4(+)T-cells as well as in T(regs). Skewing of T-cell subsets towards Th17 cells was observed in SLE-patients. Although the proportion of T(regs) was similar between SLE-patients and healthy controls, the ability of T(regs) to express IFN-γ and IL17A was impaired in SLE-patients. Even in quiescent SLE-patients T-cell homeostasis is aberrant in terms of skewing towards IL-17 producing T-cells
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a FOXP3 protein, human
|2 NLM
|
650 |
|
7 |
|a Forkhead Transcription Factors
|2 NLM
|
650 |
|
7 |
|a IL17A protein, human
|2 NLM
|
650 |
|
7 |
|a Interleukin-17
|2 NLM
|
650 |
|
7 |
|a Interleukin-4
|2 NLM
|
650 |
|
7 |
|a 207137-56-2
|2 NLM
|
650 |
|
7 |
|a Interferon-gamma
|2 NLM
|
650 |
|
7 |
|a 82115-62-6
|2 NLM
|
700 |
1 |
|
|a Bijl, Marc
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huitema, Minke G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Limburg, Pieter C
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kallenberg, Cees G M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Abdulahad, Wayel H
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 141(2011), 2 vom: 15. Nov., Seite 197-204
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:141
|g year:2011
|g number:2
|g day:15
|g month:11
|g pages:197-204
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2011.08.005
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 141
|j 2011
|e 2
|b 15
|c 11
|h 197-204
|